ABBVIE INC. DL-,01 (4AB.DE) Financials
4AB.DE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | ? | ? |
| 2023-12-31 | 134.7 billion | 124.3 billion |
| 2023-09-30 | 136.2 billion | 124.1 billion |
| 2023-06-30 | 135.4 billion | 122.5 billion |
4AB.DE Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | ? | ? |
| 2023-12-31 | 4.5 billion | 125.0 million |
| 2023-09-30 | 7.4 billion | 130.0 million |
| 2023-06-30 | 6.1 billion | 179.0 million |
4AB.DE Net Income
| Date | Net Income |
|---|---|
| 2024-03-31 | 1.4 billion |
| 2023-12-31 | 824.0 million |
| 2023-09-30 | 1.8 billion |
| 2023-06-30 | 2.0 billion |
4AB.DE Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 12.8 billion | - | - |
| 2023-12-31 | 12.8 billion | - | - |
| 2023-09-30 | 13.3 billion | - | - |
| 2023-06-30 | 8.8 billion | - | - |
4AB.DE Shares Outstanding
4AB.DE Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | - | 2.1 billion | - | - |
| 2023-12-31 | 205.0 million | 1.9 billion | 993.0 million | 2.2 billion |
| 2023-09-30 | 219.0 million | 1.7 billion | 3.4 billion | - |
| 2023-06-30 | 178.0 million | 1.7 billion | 3.3 billion | - |
4AB.DE Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 12.3 billion | 4.0 billion |
| 2023-12-31 | 14.3 billion | 5.7 billion |
| 2023-09-30 | 13.9 billion | 6.5 billion |
| 2023-06-30 | 13.9 billion | 4.2 billion |
4AB.DE
Price: €150.14
Dividend Yield: 3.86%
Forward Dividend Yield: 3.82%
Payout Ratio: 225.88%
Dividend Per Share: 5.76 EUR
Earnings Per Share: 2.55 EUR
P/E Ratio: 65.10
Exchange: GER
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 2151
Market Capitalization: 264.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 9
DGR3: 1.29%
DGR5: 2.27%